BioCentury
ARTICLE | Company News

Hybrigenics SA, Semaia BV deal

May 5, 2003 7:00 AM UTC

Proteomics company Hybrigenics acquired Semaia, which focuses on signal transduction in cancer, in a stock deal. Hybrigenics will use its functional proteomics technology to prioritize Semaia's target...